Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Free Cash Flow Generation Index

Latest as of December 2024: 0.18x

Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Free Cash Flow Generation Index of 0.18x as of December 2024. Free cash flow of CN¥18.76 Million represents 0% of operating cash flow (CN¥102.67 Million). Explore 301089 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.18x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥18.76 Million
CNY

Operating Cash Flow

CN¥102.67 Million
CNY

Capital Expenditures

CN¥83.91 Million
CNY

Xinxiang Tuoxin Pharmaceutical Co.Ltd. Free Cash Flow Generation Index (2019–2024)

Historical FCF Generation Index trend for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 6 annual periods. For the full cash flow conversion analysis, see 301089 cash flow conversion.

Annual Free Cash Flow Generation for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2024)

Year-by-year Free Cash Flow Generation Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. Check total reinvestment intensity of Xinxiang Tuoxin Pharmaceutical Co.Ltd. to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 0.18x CN¥18.76 Million CN¥102.67 Million CN¥83.91 Million ▲ +103.1%
2023 -5.87x CN¥-158.27 Million CN¥26.95 Million CN¥185.22 Million ▼ -1409.9%
2022 0.45x CN¥120.52 Million CN¥268.85 Million CN¥148.33 Million ▲ +147.8%
2021 -0.94x CN¥-54.53 Million CN¥58.19 Million CN¥112.73 Million ▼ -345.1%
2020 0.38x CN¥45.88 Million CN¥120.00 Million CN¥74.12 Million ▲ +224.6%
2019 0.12x CN¥10.17 Million CN¥86.38 Million CN¥76.20 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).